Drug makers are often extorted by patent trolls, but it’s something else when the troll is the U.S. government. In a landmark case, a federal jury on Tuesday rejected the Centers for Disease Control and Prevention’s gambit to extract enormous royalties from Gilead Sciences Inc. for a fictitious …